Gamaleya/Sputnik
Brazilian agency’s decision to delay authorization is political, says Sputnik V team

The Russian laboratory has provided scientific studies and affirms that the vaccine is safe

Argentina starts nationwide COVID-19 vaccinations

On December 24, the South American nation received the first 300,000 doses out of a total order of over 10 million doses of the Russian Sputnik V vaccine. In the first round it has prioritized the health workers for the administration of the vaccine.

Vaccine rollout battle: First past the post may win major market share

India’s mass vaccination plans may fail if it does not hold open discussions on its plans with health professionals and the people

COVID-19 vaccine: Rich countries might gain, poor ones might suffer

As trials for vaccine candidates continue, the question of which countries will gain access to it has become pressing. Low-income countries are likely to suffer in this regard

COVID-19 Vaccines: Moderna declares successful trial results after Pfizer

The new vaccine candidate by Moderna Inc, called mRNA-1273, has reportedly shown 94.5% efficacy against the SARS-CoV-2 in the phase III clinical trials

Vaccine distribution: Cold storage requirement for potential COVID-19 vaccine a major problem

Newsclick’s Prabir Purkayastha and immunologist Dr. Satyajit Rath discuss the challenges of taking a vaccine to the people in countries like India. They also look at the various vaccine candidates in contention

oxfam COVID vaccine supply report Rich countries corner nearly 51% supply of five major COVID-19 vaccine candidates: Oxfam

According to a recent study by Oxfam International, wealthy nations, which account for nearly 13% of the global population, have cornered a lion’s share of supply deals for vaccine candidates in phase-3 of the clinical trials